LAS VEGAS--(BUSINESS WIRE)--Feb. 23, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT.OB) announced today that its Chief Operating and Scientific Officer, Jack Jacobs, Ph.D., presented the company’s recent progress in its efforts to bring new therapeutics to the market for the treatment of stroke. His lecture was delivered on February 22, 2006 at the International Regenerative Medicine Foundation’s 3rd annual conference entitled “New Science for a Better Medicine.”
